CG Oncology CGON Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CG Oncology's investing cash flow?
- CG Oncology (CGON) reported investing cash flow of -$334.85M in Q1 2026.
- How has CG Oncology's investing cash flow changed year-over-year?
- CG Oncology's investing cash flow decreased by 79.3% year-over-year, from -$186.77M to -$334.85M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.